Holen Sie sich die Stockscreener-App
1.69
1.17%
-0.02
Handel nachbörslich:
1.72
0.03
+1.78%
Schlusskurs vom Vortag:
$1.71
Offen:
$1.74
24-Stunden-Volumen:
117.81K
Relative Volume:
0.11
Marktkapitalisierung:
$2.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.59M
KGV:
-0.00123
EPS:
-1373
Netto-Cashflow:
$-9.25M
1W Leistung:
-27.47%
1M Leistung:
-59.67%
6M Leistung:
-69.30%
1J Leistung:
-99.32%
1-Tages-Spanne:
$1.65
$1.77
1-Wochen-Bereich:
$1.60
$2.32
52-Wochen-Spanne:
$1.60
$316.92
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Firmenname
Bluejay Diagnostics Inc
Sektor
Branche
Telefon
(978) 631-0152
Adresse
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON
Vergleichen Sie BJDX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BJDX
Bluejay Diagnostics Inc
|
1.69 | 2.88M | 0 | -8.59M | -9.25M | -1,373.00 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Bluejay Diagnostics Inc Aktie (BJDX) Neueste Nachrichten
BJDX stock touches 52-week low at $2.22 amid sharp annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $2.22 amid sharp annual decline - Investing.com India
Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting - The Manila Times
Breakthrough Sepsis Test Could Predict Patient Mortality Risk, New Study Reveals - Stock Titan
Bluejay Diagnostics Secures $3.7 Million Through Warrant Inducement Transaction - citybuzz -
Small Cap Stocks To Watch NowApril 7th - MarketBeat
Bluejay Diagnostics slumps after raising $3.7M through warrant exercise deal - MSN
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com India
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.84% - Investing.com UK
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
BJDX stock touches 52-week low at $3.01 amid steep annual decline By Investing.com - Investing.com South Africa
BJDX stock touches 52-week low at $3.01 amid steep annual decline - Investing.com
Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March - Benzinga
US Markets Rebound As Global Trade Tensions Persist - Finimize
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Jack Kellogg Called The Market Bottom - timothysykes.com
Bluejay Diagnostics Plunges Premarket After Investors Agree to Exercise Warrants at Reduced Price - MarketScreener
Bluejay Diagnostics Sinks Premarket Following Investor Agreement to Exercise Warrants at 'Reduced' Price - MarketScreener
Bluejay Diagnostics enters into agreement with institutional investors - Medical Buyer
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Bluejay Diagnostics Raises $3.7M Through Warrant Deal, Stock Slides After-Hours While Retail Interest Surges - NewsBreak: Local News & Alerts
Bluejay Diagnostics (BJDX) Secures $3.7M Through Warrant Exercis - GuruFocus
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds - The Manila Times
Bluejay Diagnostics Announces Entry Into Warrant Inducement Transaction For Approximately $3.7 Million In Gross Proceeds - marketscreener.com
Bluejay Diagnostics Raises Fresh $3.7M Capital: New Warrant Deal Strengthens Balance Sheet - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Vermilion Energy Inc. Confirms First Quarter 2025 Release Date and Filing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders - Yahoo Finance
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Nasdaq Surges Over 400 Points; China Pharma Shares Plummet - Benzinga
ADDING MULTIMEDIA Altus Capital Partners Together With Centerfield Capital and ALM Management Acquire ALM Positioners, Inc. - Yahoo Finance
Ardonagh Advisory acquires ALP Holdings and its subsidiary - Yahoo Finance
Diagnostic Green Announces the Return of IC-Green® to the Market and Corporate Support for Groundbreaking Cancer Trial - Yahoo Finance
Bluejay Diagnostics: A Roller Coaster Week - timothysykes.com
IBM Acquires Hakkoda Inc., Expanding Data Expertise to Fuel Clients' AI Transformations - Yahoo Finance
Berkshire Hathaway (BRK-B) And Vltava Fund’s Investment Approach - Yahoo Finance
Is United Rentals (URI) Trading at Attractive Price? - Yahoo Finance
Stramsen Biotech Inc. Announced $25 Million Funding Commitment from GEM Global Yield LLC SCS ("GEM") - Yahoo Finance
Is It Too Late To Consider Buying Performance Food Group Company (NYSE:PFGC)? - Yahoo Finance
Oil drops to four-year low, metals fall on recession fears - Yahoo Finance
Is Enlivex Therapeutics (NASDAQ:ENLV) In A Good Position To Invest In Growth? - Yahoo Finance
Cintas Corporation (CTAS) Dropped -11% in Q4 - Yahoo Finance
Hub Group, Inc.'s (NASDAQ:HUBG) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - Yahoo Finance
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Is Adobe Inc. (ADBE) the Best High-Risk Stock to Buy According to Billionaires? - Yahoo Finance
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer - Yahoo Finance
Earnings grew faster than the favorable 19% CAGR delivered to Park-Ohio Holdings (NASDAQ:PKOH) shareholders over the last three years - Yahoo Finance
Emerging Stocks Sink Most Since 2008 as Tariff Turmoil Deepens - Yahoo Finance
Why Chanson International Holding Shares Are Trading Higher By Around 170%; Here Are 20 Stocks Moving Premarket - Benzinga
Apyx Medical (NASDAQ:APYX) & Bluejay Diagnostics (NASDAQ:BJDX) Head-To-Head Review - Defense World
At US$15.27, Is Monro, Inc. (NASDAQ:MNRO) Worth Looking At Closely? - Yahoo Finance
Finanzdaten der Bluejay Diagnostics Inc-Aktie (BJDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):